All stock lists
Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
US · Delayed Price · Currency is USD
Also listed: GBMB.F, GBM.FHealthcare · Biotechnology
1.89+1.29 (+213.75%)
Market cap
$131M
Insider Score
Health Score
Analyst consensus
Listed since
Dec 8, 1998
Website
Insider Score
––Not scored
INO Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
INO Stock Insider Trading Activity
INO stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Shea Jacqueline Elizabeth Chief Executive Officer | Tax withheld | 12,306 | $1.23 | $15.14K | New | 111,021 | May 20, 2026 | — | Form 4 |
| Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | 28,296 | — | $0 | New | 123,327 | May 20, 2026 | — | Form 4 |
| KIES PETER CFO | Tax withheld | 4,688 | $1.23 | $5.77K | New | 42,854 | May 20, 2026 | — | Form 4 |
| KIES PETER CFO | Option exercise | 8,700 | — | $0 | New | 47,542 | May 20, 2026 | — | Form 4 |
| Sumner Michael John Chief Medical Officer | Tax withheld | 2,693 | $1.23 | $3.31K | New | 42,038 | May 20, 2026 | — | Form 4 |
| Sumner Michael John Chief Medical Officer | Option exercise | 9,450 | — | $0 | New | 44,731 | May 20, 2026 | — | Form 4 |
| Humeau Laurent Chief Scientific Officer | Tax withheld | 2,163 | $1.23 | $2.66K | New | 46,823 | May 20, 2026 | — | Form 4 |
| Humeau Laurent Chief Scientific Officer | Option exercise | 6,027 | — | $0 | New | 48,986 | May 20, 2026 | — | Form 4 |
| Humeau Laurent Chief Scientific Officer | Tax withheld | 1,712 | $1.30 | $2.23K | New | 42,959 | May 15, 2026 | — | Form 4 |
| Humeau Laurent Chief Scientific Officer | Option exercise | 4,771 | — | $0 | New | 44,671 | May 15, 2026 | — | Form 4 |
| KIES PETER CFO | Tax withheld | 2,571 | $1.30 | $3.34K | New | 38,842 | May 15, 2026 | — | Form 4 |
| KIES PETER CFO | Option exercise | 4,771 | — | $0 | New | 41,413 | May 15, 2026 | — | Form 4 |
| Shea Jacqueline Elizabeth Chief Executive Officer | Tax withheld | 7,717 | $1.30 | $10.03K | New | 95,031 | May 15, 2026 | — | Form 4 |
| Shea Jacqueline Elizabeth Chief Executive Officer | Option exercise | 17,744 | — | $0 | New | 102,748 | May 15, 2026 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Tax withheld (F) — Shares withheld to pay tax or an exercise price
- Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.